Vidofludimus calcium anhydrous is the calcium salt form of vidofludimus, an orally bioavailable compound that inhibits dihydroorotate dehydrogenase (DHODH). It is used in pharmaceutical research and manufacturing as an active pharmaceutical ingredient for its potential anti-inflammatory, immunomodulating, and anti-viral properties.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Vidofludimus calcium anhydrous?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Cabazitaxel N-1
pharmaceutical raw material
Rifamycin s
pharmaceutical raw material
Pneumocandin B0
pharmaceutical raw material
2-(((2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)methoxy)methoxy)-3-hydroxypropyl D-valinate
pharmaceutical raw material
Vidofludimus
pharmaceutical raw material
calcium bis(2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylate)
KWSJBFAXOPFZSO-UHFFFAOYSA-L
COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)[O-])F.COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)[O-])F.[Ca+2]
Sourcing Vidofludimus calcium anhydrous?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.